Mackay Martin

Mackay Martin is listed in filings as Director at Charles River Laboratories International Inc. This profile follows SEC Form 4 activity through May 11, 2026, including 13 public disclosures. Recent filings connect the profile to Charles River Laboratories International Inc (CRL), Rallybio Corporation (RLYB), and SPRINGWORKS THERAPEUTICS INC (SWTX). The current snapshot covers public activity from Jul 30, 2024 to May 11, 2026. Reported amounts are shown as $255.4K to $80.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.